News

Bayer executives recently met with executives of Monsanto to privately discuss a negotiated acquisition of Monsanto Company.

UC Riverside study explains how distribution of two forms of a transcription factor in the colon influence risk of disease.

Company has received U.S. patent covering fundamental methods in comprehensive genomic analysis in cancer.

Collaboration aims to accelerate adoption of Next-Generation Sequencing in routine clinical diagnostics.

Company has announced collaboration with Caribou Biosciences for leading CRISPR-Cas9 gene editing technology in livestock species.

Company has expanded its service capabilities at four U.S. sites to offer identification of microorganisms using the latest MicroSEQ® library and an Applied Biosystems/Hitachi 3500 Genetic Analyzer.

As part of Qlucore’s commitment to business expansion in the US, Yana Stackpole has been appointed as Sales Manager for North America.

A contagious form of cancer that can spread between dogs during mating has highlighted the extent to which dogs accompanied human travellers throughout our seafaring history. But the tumours also provide surprising insights into how cancers evolve by ‘stealing’ DNA from their host.

Clues about the evolution of the giraffe’s long neck have now been revealed by new genome sequencing.

Visionary, up to $2 billion multi-year alliance to focus on development of new gene therapy and gene editing technologies and create a therapeutic platform for a broad range of diseases.